About 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hellenic Institute for the Study of Sepsis
4
Bayer
1
Fab'entech
1
Summit Therapeutics
1
Clinical Trials at 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO
During the past decade, 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20%
of trials that started reached the finish line.
Safety and Pharmacokinetics of FBR-002 for the Treatment of Patients Hospitalized With COVID-19 in Need of Supplemental Oxygen and at Risk of Severe Outcome
A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke
2022-12-05
2025-08-25
Recruiting
18,000
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO
According to Clinical.Site data, the most researched conditions in "2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO" are
"COVID-19" (3 trials), "Corona Virus Infection" (2 trials), "Virus Diseases" (2 trials), "Atrial Fibrillation" (1 trials) and "Clostridioides Difficile Infection" (1 trials). Many other conditions were trialed in "2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO" in a lesser frequency.
Clinical Trials Intervention Types at 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO
Most popular intervention types in "2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO" are "Drug" (6 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Anakinra" (2 trials), "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO
The vast majority of trials in "2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO" are
7 trials for "All" genders.
Clinical Trials Status at 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO
Currently, there are NaN active trials in "2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in 2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".